Life Science

Più recente

281 a 290 di 399
  • Time barred damages claim in vitamins cartel likely to prompt earlier follow on actions Accesso limitato

    Articolo

    Ultima consultazione: 28 May 2009 / Inviato: 28 May 2009

    The Court of Appeal has dealt a blow to claimants who were seeking damages arising from the vitamins cartel.

  • The Rome II Regulation: what you need to know Accesso limitato

    Articolo

    Ultima consultazione: 19 May 2009 / Inviato: 19 May 2009

    On 21 January 2009 the Rome II Regulation (Reg 864/2007) came into force in all EU Member States with the exception of Denmark. The regulation supersedes the previous English laws regarding torts in private international law.

  • Implementation of the amended PRC technology transfer measures - technology export Accesso limitato

    Articolo

    Ultima consultazione: 11 May 2009 / Inviato: 11 May 2009

    As previously reported, the Ministry of Commerce (MOFCOM) issued a consultation draft in respect of the Measures for the Administration of Prohibited or Restricted Technology Export (the Measures) on 18 July 2008. The final Measures were recently published on 20 April 2009 and will come into force on 20 May 2009.

  • What about FDA preemption now? Accesso limitato

    Articolo

    Ultima consultazione: 07 May 2009 / Inviato: 07 May 2009

    A review of the long awaited judgment in the US case Wyeth v Levine which asks what the future holds for the liability of drug manufacturers.

  • Dutch court denies liability claim issued against British American Tobacco Accesso limitato

    Articolo

    Ultima consultazione: 07 May 2009 / Inviato: 07 May 2009

    While smoking may kill, the Dutch courts won`t award damages to those who did it anyway.

  • How China’s new patent law will affect life science companies Accesso limitato

    Articolo

    Ultima consultazione: 21 January 2010 / Inviato: 22 April 2009

    In a bid to secure more foreign investment and comply with international conventions, China introduced a new patent law in October 2009. The new law simplifies patent filing requirements for research oriented companies while bringing China into line with the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS). This article highlights key changes under the amended Patent Law and the related Implementing Regulations.

  • Life Sciences March/April 2009 Accesso limitato

    Newsletter

    Ultima consultazione: 03 April 2009 / Inviato: 03 April 2009

    March and April 2009 review of legal and general developments affecting the Life Sciences sector.

  • The credit crunch and financing medical equipment Accesso limitato

    Articolo

    Ultima consultazione: 25 March 2009 / Inviato: 25 March 2009

    The impact of the credit crunch is being felt in all sectors. Hospitals and private medical facilities need up to date, state of the art, equipment to provide the best service possible and, thereby, for the private sector to remain competitive. However, the capital expenditure required can put a strain on budgets and balance sheets, which are already under considerable pressure.

  • House of Lords upholds EPO approach to insufficiency Accesso limitato

    Articolo

    Ultima consultazione: 21 January 2010 / Inviato: 25 February 2009

    Biogen insufficiency does not apply to ordinary product claims, even when the `invention` lies in the way of making the product, not the product itself.

  • Employee inventors win compensation in the UK - for the first time! Accesso limitato

    Articolo

    Ultima consultazione: 21 January 2010 / Inviato: 19 February 2009

    Kelly v GE Healthcare is a groundbreaking judgment of particular interest to the pharmaceutical industry and to any other company for whom a single product can supply a very significant proportion of income.

281 a 290 di 399